AD-2112
- Generic Name
- AD-2112
Evaluating the Pharmacokinetic Interactions and Safety Between AD-2111 and AD-2112
- First Posted Date
- 2020-05-06
- Last Posted Date
- 2020-11-06
- Lead Sponsor
- Addpharma Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT04375865
- Locations
- 🇰🇷
Kyungpook National University Hospital, Daegu, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath